S'identifier

Hans-Georg Kopp

Dept. of Hematology,
Oncology and Immunology,
Dept. of Hematology, Oncology and Immunology

University of Tübingen

BIOGRAPHY

Hans-Georg Kopp has not added Biography.

If you are Hans-Georg Kopp and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation.

Journal of cancer research and clinical oncology Apr, 2005 | Pubmed ID: 15616828

Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells.

Stem cells and development May, 2010 | Pubmed ID: 19422288

Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors.

Journal of cancer research and clinical oncology Dec, 2010 | Pubmed ID: 20217128

Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban in Klippel-Trénaunay syndrome.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Oct, 2013 | Pubmed ID: 24030117

Enhanced eryptosis contributes to anemia in lung cancer patients.

Oncotarget Mar, 2016 | Pubmed ID: 26872376

NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.

Nature communications 10, 2017 | Pubmed ID: 28970470

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

Cancer research Aug, 2018 | Pubmed ID: 29789417

Impact of surgery in patients with metastatic soft tissue sarcoma: A monocentric retrospective analysis.

Journal of surgical oncology Jul, 2018 | Pubmed ID: 29953623

Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient.

Annals of hematology Jul, 2018 | Pubmed ID: 29980874

INSTITUTIONS

University of Tübingen

JOVE ARTICLES

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Alexander R. Fuchs¹,

Melanie Märklin¹,

Jonas S. Heitmann¹,

Stefan Futterknecht¹,

Michael Haap²,

Stefan Wirths¹,

Hans-Georg Kopp¹,

Clemens Hinterleitner¹,

Daniela Dörfel¹,

Martin R. Müller¹

¹Dept. of Hematology, Oncology and Immunology, University of Tübingen,

²Dept. of Endocrinology, Diabetology, Clinical Pathology and Metabolism, University of Tübingen

Cancer Research

Confidentialité

Conditions d'utilisation

Politiques

Contactez-nous

RECOMMANDER À LA BIBLIOTHÈQUE

NEWSLETTERS JoVE

Recherche

JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives

Enseignement

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Faculty Site

Auteurs

Vue d'ensemble
Processus de publication
Comité éditorial
Domaines et politique de publication
Révision par les pairs
FAQ
Soumettre

Bibliothécaires

Vue d'ensemble
Témoignages
Abonnements
Accès
Ressources
Conseil consultatif des bibliothèques
FAQ

À PROPOS DE JoVE

Vue d'ensemble
Direction
Blog
JoVE Help Center

Hans-Georg Kopp

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Dept. of Hematology,Oncology and Immunology,Dept. of Hematology, Oncology and Immunology

University of Tübingen

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Dept. of Hematology,
Oncology and Immunology,
Dept. of Hematology, Oncology and Immunology